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ABSTRACTS 
EFFECT OF HYALURONIDASE ON URINE AND ITS POSSIDLE SIG-
NIFICANCE IN RENAL LITHIASIS. In 
1950, it was observed that subcutaneous 
injections of hyaluronidase (wydase), 
mixed with isotonic sodium chloride solu-
tion, resulted in clearing of urine in pa-
tients who previously had turbid urine 
with much sedimentation. The effect of 
hyaluronidase was manifest within 30 
minutes after injection and persisted for 
24 to 72 hours. 
In attempting to establish a mechanism 
by which the hyaluronidase produced this 
effect, urine specimens were examined 
under a microscope equipped with a 
standard dark-field condenser to ascertain 
whether hyaluronidase caused a change 
in the colloid-chemical condition of the 
urine. Preliminary observations appeared 
to establish a correlation between the in-
jection of hyaluronidase and the number 
of colloidal particles discernible in the 
urine sample. Certain colloidal pheno-
mena (e.g., adhesion) made the statisti-
cal validity of this method questionable. 
In addition, considerable dispute as to the 
significance of such examination is al-
ready apparent. Since that time, however, 
a technique of preparing urine samples 
for examination with the Leitz "Ultro-
pak" microscope has been developed. 
With this method we have been able to 
offer visual proof that the injection of 
hyaluronidase results in the release into 
the urine of a protective colloid which not 
only disperses crystalline matter already 
present but also inhibits the formation 
and growth of new crystalline matter. 
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Since, in the initial studies, the addition 
of hyaluronidase to voided urine did not 
bring about the same alteration in colloi-
dal properties that the injection of hyalur-
onidase did, it was suggested that hyalur-
onidase acted indirectly by releasing 
hyaluronate from the site of injection 
and that further amounts of hyaluronate 
were excreted into the urine during the 
period of restoration of hyaluronate at 
the site of injection. We have since estab-
lished that potassium hyaluronate is a 
powerful peptizing and dispersing agent. 
The evidence thus far is very suggestive 
that a hyaluronidase substrate is a com-
ponent of normal urine and that it plays 
an important part in maintaining the 
proper colloid-crystalloid balance. 
It is accepted, although not conclusively 
proved, that the formation of kidney 
stones is the result of an imbalance of the 
colloidal and crystalloidal matter present 
in the urine. Since hyaluronidase seems 
to influence this balance, an investigation 
of the possibilities offered by employing 
hyaluronidase as a therapeutic agent in 
the treatment and prevention of renal 
calculi seemed to be of interest. 
It was concluded that subcutaneous in-
jection of hyaluronidase, mixed with iso-
tonic sodium chloride, pronouncedly in-
creases the protective urinary colloids and 
causes clearing of turbidity and sediment 
in the urine of the majority of cases 
studied. Hyaluronidase therapy has been 
effective in preventing calculus formation 
or reformation during a period of 11 to 21 
months in 19 of 24 patients, 79 percent in 
99 
whom kidney stones previously formed at 
a rapid rate. 
Butt, A. J., M.D.; Hauser, E. A., Ph.D.; SeiHer, 
J., M.D.! Effe<;t C!f Hyaluronidase on Urine and 
Its Possible Slgmficance in Renal Lithiasis. The 
Journal of The American Medical Association. 
150:1096-1098 (November) 1952. 
A NTIBIOTIC SYNERGISM AND AN-
'I1AGONISM. Fixed synergistic drug 
combinations against specific organisms 
do not exist. The author found that a 
broad division of antibiotic agents into 
two groups would permit formulation of 
certain predictions as to their combined 
drug action. The two groups are as fol-
lows: 
Group I: Penicillin; streptomycin; baci-
tracin; and neomycin. 
Group II: Aureomycin; chlorampheni-
col; and terramycin. 
Combinations of the first group were 
found to be frequently synergistic, 
occasionally indifferent, but never anta-
gonistic. Combinations of the second 
group were neither synergistic nor anta-
gonistic, but produced often simple addi-
tive effects in the clinical tests. This effect 
could presumably likewise be obtained by 
increasing the dose of the single member. 
When, on the other hand, a member 
of group II was combined with one of 
group I, their combined effect depended 
apparently on the susceptibility of the 
micro-organism to the group I agent. Ac-
cording to the results of the experiment, 
antagonism between the two groups may 
be expected with a micro-organism sus-
ceptible to a group I drug, and synergism 
may result if the organism is resistant to 
a group I drug. 
This scheme has proved helpful in the 
selection of drug combinations for the 
treatment of specific infections. 
[Jawetz, E:, M.D., P1:t.D., Antibiotic Synergism 
and Antagomsm. Archives of Internal Medicine. 
90:301 (September) 1952.] 
T REATMENT FAILURE WITH PENI-CILLIN. Clinical experience has 
shown that large doses of penicillin may 
be ineffective in overcoming an infection, 
despite the fact that in vitro tests show 
100 
the infective organism to be sensitive to 
the antibiotic. In some cases, refractori-
ness may be attributed either to inade-
quate concentrations of penicillin reach-
ing the pathogenic organisms because of 
a walling off of the focus of infection or 
to the development of resistant organisms. 
Another explanation for refractoriness 
namely, that in older foci of infection th~ 
organisms are no longer multiplying or 
metabolizing as actively as in the fresh 
infection, has recently been explored by 
Eagle. 
Mice were given intramuscular in-
jections of known numbers of a highly 
virulent strain of group A streptococci, 
and treatment with penicillin was begun 
at varying intervals after inoculation. 
Animals were then killed at either one 
two, four, or eight hours after treatment 
and the inoculated muscle emulsified and 
subcultured to determine the residual 
viable organisms. 
Preliminary experiments with un-
treated animals revealed a rapid increase 
in number of organisms recovered from 
muscle during the first nine hours after 
inoculation, with only a moderate increase 
occurring in the next 15 hours. In animals 
treated with penicillin during the first six 
hours of the infection, a rapid bactericidal 
effect was noted and no deaths occurred 
in animals set aside for mortality studies. 
If treatment was delayed 12 hours, how-
ever, the same dose of penicillin exerted 
only a slow and irregular bactericidal 
effect and the mortality rate did not differ 
significantly from that of untreated con-
trols. In order to effect a cure when treat-
ment was delayed, it was found necessary 
to continue treatment for six to eight 
days. 
In discussing these results, Eagle draws 
attention to the well-known fact that peni-
cillin kills bacteria most effectively in 
vitro when they are actively metabolizing 
a favorable medium and suggests that in 
older infections the organisms have multi-
plied to such an extent that they exhaust 
the surrounding tissue of nutrilites faster 
than they can be supplied by the blood 
stream. Furthermore, as inflammation sets 
in, the leukocytes may compete with 
these bacteria Lor the nutrilites, while 
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local accumulation of products toxic to the 
bacteria may further reduce their meta-
bolic activity. This concept is strength-
ened by the observation that, when larger 
inoculations were used, the time during 
which penicillin exerted a rapid bacter-
icidal effect was shortened. 
The author suggests that exhaustion of 
favorable foodstuffs may explain the para-
doxical treatment failure sometimes ob-
served with penicillin. Since the physiolo-
gical state of the organisms rather than 
the concentration of the penicillin appears 
to be the limiting factor in such a refract-
ory state, prolongation of treatment or the 
use of penicillin in combination with an 
antibiotic, the effectiveness of which is 
not restricted to actively metabolizing 
organisms, would appear at times to be 
a more logical approach to successful 
therapy than the use of increased dosages 
of penicillin. 
[Editorial. Treatment Failure with Penicillin. 
The Journal of The American Medical Associ-
ation. 151:301 (January) 1953.] 
~OME PROPERTIES OF THE CAUS-
U) ATIVE AGENT OF TRANSMISSI-
BLEGASTROENTERITIS IN SWINE. 
Transmissible gastroenteritis, a cause of 
deaths in many thousands of baby pigs, 
has been reported in all the Midwestern 
states. Because this disease spreads and 
kills young pigs so rapidly, treatment 
and control have been very discouraging. 
In order to clarify some of the char-
acteristics of the causative agent in this 
disease, these studies were made. (1) The 
survival of the causative agent under 
various conditions; (2) the effect of 
centrifugation on the concentration of the 
etiological agent; (3) the susceptibility of 
laboratory animals to the causative agent; 
and (4), the effect of treatment. The 
animals used for these studies included 96 
baby pigs, 19 guinea pigs, 43 mice, 4 ham-
sters, and 5 rabbits. 
A summary of the results of this study 
revealed the following: (1) The causative 
agent remained infective for young pigs 
after three days drying at 67° to 70°F. (2) 
Supernatant fluid from centrifuged 
ground gastrointestinal tract containing 
.05 percent formalin was not infective. 
(3) Ground gastrointestinal tract pro-
duced disease after being stored for three 
years and six months at -28°C. (4) 
Centrifugation of filtrates at 15,000 to 
18,000 revolutions per minute for thirty 
to sixty minutes apparently concentrated 
the causative agent to some extent. (5) 
No host except swine has been found for 
the causative agent of transmissible gas-
troenteritis. (6) Under the conditions of 
this study, none of the therapeutic agents 
used was of any value in the treatment 
of transmissible gastroenteritis. They in-
cluded streptomycin, aureomycin, chloro-
mycetin, penicillin, sulfadiazine, sulfa-
thaladine and sulfamethazine. 
[ Bay, W. W., D.V.M., M.S.; Doyle, L. P., D.V.M., 
M.S., Ph.D; Hutchings, L. M., D.V.M., M.S., 
Ph.D., Some Properties of the Causative Agent 
of Transmissible Gastroenteritis in Swine. Amer-
ican Journal of Veterinary Research. 13:318-321 
(July) 1952.] 
The objectives of the Public Health 
Subcommittee of the National Brucellosis 
Committee are: (1) To inform the 
American farmer of the danger to him-
self and the public of brucellosis infec-
tion; (2) To recommend procedures 
which will lessen the danger of human 
infection. The following outline was sub-
mitted for the approval of the committee: 
1. That universal pasteurization of milk 
and all dairy products be encouraged. 
2. That only disease-free herds be per-
mitted a Grade A classification for milk 
and milk products. 
3. That steps be taken to educate farm-
ers of the danger, to themselves and their 
families, of keeping infected animals. 
4. That educational materials be made 
available to personnel in the animal-
handling industries, other than the live-
stock farmer. pointing out the dangers 
of occupational brucellosis, and the means 
whereby infection may be avoided. 
5. That the subcommittee review new 
public health problems and suggestions 
as they are received, and encourage pri-
vate and governmental agencies to de-
velop methods of public health educa-
tion. 
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